Skip to content

A two part, randomized, double-blind, placebo-controlled, parallel group SAD and MD clinical study to evaluate the safety, tolerability and preliminary efficacy of an inhaled (nebulized) phage cocktail in healthy subjects and in patients with chronic colonization of the lung with Pseudomonas aeruginosa

Status
Withdrawn
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2022-503145-22-00
Acronym
Phage4Cure-001
Enrollment
32
Registered
2023-07-07
Start date
Unknown
Completion date
Unknown
Last updated
2023-07-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pseudomonas colonization

Interventions

None listed

Sponsors

Charite Research Organisation GmbH
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Countries

Germany

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026